CSPC Pharmaceutical Statistics
Share Statistics
CSPC Pharmaceutical has 2.91B
shares outstanding. The number of shares has increased by -2.88%
in one year.
Shares Outstanding | 2.91B |
Shares Change (YoY) | -2.88% |
Shares Change (QoQ) | -1.72% |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 14,250 |
FTD / Avg. Volume | 53.55% |
Short Selling Information
The latest short interest is 3.32K, so 0% of the outstanding
shares have been sold short.
Short Interest | 3.32K |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 12.43 and the forward
PE ratio is null.
CSPC Pharmaceutical's PEG ratio is
-0.39.
PE Ratio | 12.43 |
Forward PE | n/a |
PS Ratio | 1.85 |
Forward PS | 0 |
PB Ratio | 1.67 |
P/FCF Ratio | 28.99 |
PEG Ratio | -0.39 |
Financial Ratio History Enterprise Valuation
CSPC Pharmaceutical has an Enterprise Value (EV) of 208.91B.
EV / Sales | 7.2 |
EV / EBITDA | 30.01 |
EV / EBIT | 46.07 |
EV / FCF | 112.57 |
Financial Position
The company has a current ratio of 2.27,
with a Debt / Equity ratio of 0.02.
Current Ratio | 2.27 |
Quick Ratio | 1.95 |
Debt / Equity | 0.02 |
Debt / EBITDA | 0.07 |
Debt / FCF | 0.27 |
Interest Coverage | 122.87 |
Financial Efficiency
Return on Equity is 13.41% and Return on Invested Capital is 11.85%.
Return on Equity | 13.41% |
Return on Assets | 9.75% |
Return on Invested Capital | 11.85% |
Revenue Per Employee | $1,355,572.62 |
Profits Per Employee | $202,244.63 |
Employee Count | 21,400 |
Asset Turnover | 0.65 |
Inventory Turnover | 2.78 |
Taxes
Income Tax | 1.24B |
Effective Tax Rate | 22.23% |
Stock Price Statistics
The stock price has increased by 5.31% in the
last 52 weeks. The beta is 0.72, so CSPC Pharmaceutical's
price volatility has been higher than the market average.
Beta | 0.72 |
52-Week Price Change | 5.31% |
50-Day Moving Average | 2.79 |
200-Day Moving Average | 2.65 |
Relative Strength Index (RSI) | 69.02 |
Average Volume (20 Days) | 26,611 |
Income Statement
In the last 12 months, CSPC Pharmaceutical had revenue of 29.01B
and earned 4.33B
in profits. Earnings per share was 1.48.
Revenue | 29.01B |
Gross Profit | 20.3B |
Operating Income | 5.37B |
Net Income | 4.33B |
EBITDA | 6.96B |
EBIT | 5.62B |
Earnings Per Share (EPS) | 1.48 |
Full Income Statement Balance Sheet
The company has 6.78B in cash and 507.33M in
debt, giving a net cash position of 6.27B.
Cash & Cash Equivalents | 6.78B |
Total Debt | 507.33M |
Net Cash | 6.27B |
Retained Earnings | 23.34B |
Total Assets | 44.39B |
Working Capital | 12.25B |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was 4.53B
and capital expenditures -2.68B, giving a free cash flow of 1.86B.
Operating Cash Flow | 4.53B |
Capital Expenditures | -2.68B |
Free Cash Flow | 1.86B |
FCF Per Share | 0.16 |
Full Cash Flow Statement Margins
Gross margin is 69.97%, with operating and profit margins of 18.5% and 14.92%.
Gross Margin | 69.97% |
Operating Margin | 18.5% |
Pretax Margin | 19.23% |
Profit Margin | 14.92% |
EBITDA Margin | 24% |
EBIT Margin | 18.5% |
FCF Margin | 6.4% |